History of hepatocellular carcinoma status post TACE RFA. ABDOMEN:LIVER, BILIARY TRACT: Interval decrease in perihepatic fluid. Cirrhotic liver morphology. The vessels are patent. Esophageal varices.The segment 6 ablation cavity measures approximately 4.5 x 4.4 cm with internal debris/hemorrhage. No abnormal enhancement to suggest residual or recurrent tumor.No new suspicious arterial enhancing focus. Several peripheral wedge shaped areas of arterial enhancement without washout or other signal abnormality are compatible with transient hepatic intensity differences.The vessels are patent.SPLEEN: No significant abnormality noted.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral renal cysts are not significantly changed. Mildly T2 hypointense, 1.3 cm minimally enhancing right interpolar region lesion is not significantly changed dating back to 2014.RETROPERITONEUM, LYMPH NODES: Mild atherosclerotic plaque. BOWEL, MESENTERY: Esophageal varices.BONES, SOFT TISSUES: Fat-containing ventral hernia. L1 and L2 vertebral body hemangiomas.OTHER: No significant abnormality noted.
1.Stable post-ablation changes without evidence of residual or recurrent disease.2.Cirrhotic liver with periesophageal varices.3.Stable minimally enhancing right renal interpolar region 1.3 cm lesion is not significantly changed dating back to 2014 and indeterminate but a papillary sub-type renal cell carcinoma cannot be entirely excluded.